The Foundation for Sarcoidosis Research (FSR) has hosted a virtual session attended by people with pulmonary sarcoidosis and…
Steve Bryson, PhD
Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new vaccines and medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Steve Bryson, PhD
aTyr Pharma is launching a Phase 3 clinical trial to evaluate the safety and effectiveness of efzofitimod (ATYR1923) in…
The risks of death and rejection after heart transplant for people with advanced cardiac sarcoidosis were similar to those…
A protein called neurofilament light chain (NFL), which supports nerve fibers, is elevated in adults with neurosarcoidosis — and…
A rare case of sarcoidosis affecting only the spleen was successfully diagnosed using tissue analysis, after imaging…
A professor at Northwestern University has been awarded a $50,000 American Thoracic Society (ATS)/Mallinckrodt Pharmaceuticals Research Grant to study…
Three months of treatment with the common, generic antibiotic azithromycin safely reduced the…
People with coexisting sarcoidosis and inflammatory bowel disease…
A large-scale analysis of proteins in bronchoalveolar lavage cells and fluid isolated from the lungs of people with…
Mycophenolate Mofetil May Be Effective as Alternative Sarcoidosis Treatment, Small Study Suggests
Mycophenolate mofetil (MMF) significantly reduced disease symptoms in people with sarcoidosis, and helped to reduce their daily…